Insights into ion channels to identify drug target for neuropathic pain management

Abdel-Salam OME, Mózsik G (2023) Capsaicin, the vanilloid receptor TRPV1 agonist in neuroprotection: mechanisms involved and significance. Neurochem Res 48:3296–3315

CAS  PubMed  PubMed Central  Google Scholar 

Aghazadeh Tabrizi M, Baraldi PG, Baraldi S et al (2017) Medicinal chemistry, pharmacology, and clinical implications of TRPV1 receptor antagonists. Med Res Rev 37:936–983

PubMed  Google Scholar 

Ahern GP, Brooks IM, Miyares RL, Wang X (2005) Extracellular cations sensitize and gate capsaicin receptor TRPV1 modulating pain signaling. J Neurosci 25:5109–5116

CAS  PubMed  PubMed Central  Google Scholar 

Ahuja S, Mukund S, Deng L et al (2015a) Structural basis of Nav1.7 inhibition by an isoform-selective small-molecule antagonist. Science. https://doi.org/10.1126/science.aac5464

PubMed  Google Scholar 

Ahuja S, Mukund S, Deng L, et al (2015b) Structural basis of Nav1. 7 inhibition by an isoform-selective small-molecule antagonist. Science (80-) 350:aac5464

Alam KA, Svalastoga P, Martinez A et al (2023) Potassium channels in behavioral brain disorders. Molecular mechanisms and therapeutic potential: a narrative review. Neurosci Biobehav Rev. https://doi.org/10.1016/j.neubiorev.2023.105301

PubMed  Google Scholar 

Alsaloum M, Dib-Hajj SD, Page DA et al (2025) Voltage-gated sodium channels in excitable cells as drug targets. Nat Rev Drug Discov. https://doi.org/10.1038/s41573-024-01108-x

PubMed  Google Scholar 

Anand S, Rajagopal S (2023) A comprehensive review on the regulatory action of TRP channels: a potential therapeutic target for nociceptive pain. Neurosci Insights 18:26331055231220340. https://doi.org/10.1177/26331055231220340

PubMed  PubMed Central  Google Scholar 

SB Andavan G, Lemmens-Gruber R (2011) Voltage-gated sodium channels: mutations, channelopathies and targets. Curr Med Chem 18:377–397

Andrejic N, Božovic I, Moradi H et al (2025) Neuropathic pain management: a focused review of current treatments and novel data from main ongoing clinical trials. Expert Opin Investig Drugs. https://doi.org/10.1080/13543784.2025.2473692

PubMed  Google Scholar 

Aurilio C, Pota V, Pace MC et al (2008) Ionic channels and neuropathic pain: phisiopatology and applications. J Cell Physiol 215:8–14

CAS  PubMed  Google Scholar 

Bamps D, Vriens J, de Hoon J, Voets T (2021) TRP channel cooperation for nociception: therapeutic opportunities. Annu Rev Pharmacol Toxicol 61:655–677. https://doi.org/10.1146/annurev-pharmtox-010919-023238

CAS  PubMed  Google Scholar 

Baron R (2006) Mechanisms of disease: neuropathic pain—a clinical perspective. Nat Clin Pract Neurol 2:95–106

PubMed  Google Scholar 

Bautista DM, Sigal YM, Milstein AD et al (2008) Pungent agents from Szechuan peppers excite sensory neurons by inhibiting two-pore potassium channels. Nat Neurosci 11:772–779. https://doi.org/10.1038/nn.2143

CAS  PubMed  PubMed Central  Google Scholar 

Beich SS, Kokoti L, Al-Karagholi MA-M (2025) Activation of K(ATP) channels in pain modulation: a systematic review of preclinical studies. Front Physiol 16:1444270. https://doi.org/10.3389/fphys.2025.1444270

PubMed  PubMed Central  Google Scholar 

Benarroch EE (2013) HCN channels: function and clinical implications. Neurology 80:304–310

PubMed  Google Scholar 

Bevan S, Hothi S, Hughes G et al (1992) Capsazepine: a competitive antagonist of the sensory neurone excitant capsaicin. Br J Pharmacol 107:544–552. https://doi.org/10.1111/j.1476-5381.1992.tb12781.x

CAS  PubMed  PubMed Central  Google Scholar 

Biel M, Wahl-Schott C, Michalakis S, Zong X (2009) Hyperpolarization-activated cation channels: from genes to function. Physiol Rev 89:847–885

CAS  PubMed  Google Scholar 

Blackburn-Munro G, Jensen BS (2003) The anticonvulsant retigabine attenuates nociceptive behaviours in rat models of persistent and neuropathic pain. Eur J Pharmacol 460:109–116

CAS  PubMed  Google Scholar 

Borgini M, Mondal P, Liu R, Wipf P (2021) Chemical modulation of Kv7 potassium channels. RSC Med Chem 12:483–537. https://doi.org/10.1039/d0md00328j

CAS  PubMed  PubMed Central  Google Scholar 

Brinkman DL, Burnell JN (2009) Biochemical and molecular characterisation of cubozoan protein toxins. Toxicon 54:1162–1173

CAS  PubMed  Google Scholar 

Brito R, Sheth S, Mukherjea D et al (2014) TRPV1: a potential drug target for treating various diseases. Cells 3:517–545

CAS  PubMed  PubMed Central  Google Scholar 

Broad LM, Suico JG, Turner PK et al (2025) Preclinical and clinical evaluation of a novel TRPA1 antagonist LY3526318. Pain. https://doi.org/10.1097/j.pain.0000000000003570

PubMed  Google Scholar 

Brooks A, Hornbach A, Smith JE, et al (2025) Efficacy of sodium channel-selective analgesics in postoperative, neuralgia, and neuropathy-related pain management: a systematic review and literature review. Int J Mol Sci 26:2460. https://doi.org/10.3390/ijms26062460

CAS  PubMed  PubMed Central  Google Scholar 

Burtscher V, Mount J, Huang J et al (2024) Structural basis for hyperpolarization-dependent opening of human HCN1 channel. Nat Commun 15:5216

CAS  PubMed  PubMed Central  Google Scholar 

Campbell JN, Meyer RA (2006) Mechanisms of neuropathic pain. Neuron 52:77–92

CAS  PubMed  PubMed Central  Google Scholar 

Cao X, Ma L, Yang F et al (2014) Divalent cations potentiate TRPV1 channel by lowering the heat activation threshold. J Gen Physiol 143:75–90

CAS  PubMed  PubMed Central  Google Scholar 

Carnevale V, Rohacs T (2016) TRPV1: a target for rational drug design. Pharmaceuticals. https://doi.org/10.3390/ph9030052

PubMed  PubMed Central  Google Scholar 

Caterina MJ, Schumacher MA, Tominaga M et al (1997) The capsaicin receptor: a heat-activated ion channel in the pain pathway. Nature 389:816–824

CAS  PubMed  Google Scholar 

Caterina MJ, Leffler A, Malmberg AB et al (2000) Impaired nociception and pain sensation in mice lacking the capsaicin receptor. Science 288:306–313. https://doi.org/10.1126/science.288.5464.306

CAS  PubMed  Google Scholar 

Cavalli E, Mammana S, Nicoletti F et al (2019) The neuropathic pain: an overview of the current treatment and future therapeutic approaches. Int J Immunopathol Pharmacol 33:2058738419838383. https://doi.org/10.1177/2058738419838383

PubMed  PubMed Central  Google Scholar 

Chen S, Xu Y, Liang Y et al (2019) Identification and characterization of a series of novel HCN channel inhibitors. Acta Pharmacol Sin 40:746–754

CAS  PubMed  Google Scholar 

Chi G, Liang Q, Sridhar A et al (2022) Cryo-EM structure of the human Kv3.1 channel reveals gating control by the cytoplasmic T1 domain. Nat Commun 13:4087. https://doi.org/10.1038/s41467-022-29594-w

CAS  PubMed  PubMed Central  Google Scholar 

Combe CL, Gasparini S (2021) Ih from synapses to networks: HCN channel functions and modulation in neurons. Prog Biophys Mol Biol 166:119–132

CAS  PubMed  PubMed Central  Google Scholar 

De Petrocellis L, Moriello AS (2013) Modulation of the TRPV1 channel: current clinical trials and recent patents with focus on neurological conditions. Recent Pat CNS Drug Discov 8:180–204. https://doi.org/10.2174/1574889808666131209124012

CAS  PubMed  Google Scholar 

Devor M (1991) Neuropathic pain and injured nerve: peripheral mechanisms. Br Med Bull 47:619–630

CAS  PubMed  Google Scholar 

Dib-Hajj SD, Black JA, Waxman SG (2009) Voltage-gated sodium channels: therapeutic targets for pain. Pain Med 10:1260–1269

PubMed  Google Scholar 

Ding W, You Z, Shen S et al (2016) Inhibition of HCN channel activity in the thalamus attenuates chronic pain in rats. Neurosci Lett 631:97–103. https://doi.org/10.1016/j.neulet.2016.08.021

CAS  PubMed  PubMed Central 

Comments (0)

No login
gif